Rapid Micro Biosystems, Inc.
RPID
NASDAQ·Healthcare·Medical - Devices·Mkt cap $59.4M
$1.31
▼ -5.07%
P/E
-2.26
Mkt Cap
$59.4M
52-Wk Range
$1.29–$4.94
52-Week Range
$1.29 - $4.94
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 51.8% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Average volatility.
Growth
Strong growth ahead
Value
Deep value opportunity - significant discount to sector peers
Momentum
Falling
-34.2% over 3m
Quality
Thin
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying RPID right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 7, 2026
Reported EPS of -$0.27 vs -$0.24 consensus (-11.0% surprise). Revenue of $8.1M vs $7.9M expected (+2.3%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-11.0%
Revenue trend · last 2Q
—
+11%
Q1 26
Q2 26
$8.0M
$8.1M
Margins · last 2Q
Gross
15.1%
Operating
-153.0%
Profit
-160.4%
Wall Street consensus
2 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: KeyBanc · May 29, 2026
vs Industry
How RPID stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.